TipRanks
PharmX Technologies Limited (AU:PHX)
ASX:PHX
Australian Market
Want to see AU:PHX full AI Analyst Report?

PharmX Technologies (PHX) Financial Statements

2 Followers

PharmX Technologies Financial Overview

PharmX Technologies's market cap is currently AU$46.80M. The company's EPS TTM is AU$-0.0039; its P/E ratio is -17.83; and it has a dividend yield of 6.52%. PharmX Technologies is scheduled to report earnings on August 26, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total RevenueAU$ 7.62MAU$ 7.32MAU$ 6.49MAU$ 6.02MAU$ 11.92M
Gross ProfitAU$ -70.00KAU$ 5.96MAU$ 5.25MAU$ 4.81MAU$ 10.52M
Operating IncomeAU$ -2.09MAU$ -1.42MAU$ -1.36MAU$ -774.00KAU$ 340.00K
EBITDAAU$ -532.00KAU$ 1.39MAU$ 1.45MAU$ 329.00KAU$ 2.54M
Net IncomeAU$ -1.83MAU$ -264.00KAU$ -1.77MAU$ -1.05MAU$ 252.00K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 2.57MAU$ 4.17MAU$ 13.14MAU$ 12.81MAU$ 5.76M
Total AssetsAU$ 27.27MAU$ 18.82MAU$ 29.86MAU$ 36.52MAU$ 30.77M
Total DebtAU$ 540.00KAU$ 894.00KAU$ 240.00KAU$ 32.00KAU$ 326.00K
Net DebtAU$ -2.03MAU$ -3.28MAU$ -12.90MAU$ -12.77MAU$ -5.43M
Total LiabilitiesAU$ 3.99MAU$ 2.90MAU$ 13.88MAU$ 14.31MAU$ 7.57M
Stockholders' EquityAU$ 23.28MAU$ 15.93MAU$ 15.97MAU$ 22.21MAU$ 23.20M
Cash Flow
Free Cash FlowAU$ 805.00KAU$ -8.16MAU$ 3.19MAU$ 10.86MAU$ 3.19M
Operating Cash FlowAU$ 825.00KAU$ -8.13MAU$ 3.21MAU$ 10.94MAU$ 3.28M
Investing Cash FlowAU$ -2.10MAU$ -695.00KAU$ 1.75MAU$ -3.57MAU$ -3.64M
Financing Cash FlowAU$ -322.00KAU$ -136.00KAU$ -4.62MAU$ -325.00KAU$ -361.00K
Currency in AUD

PharmX Technologies Earnings and Revenue History

PharmX Technologies Debt to Assets

PharmX Technologies Cash Flow

PharmX Technologies Forecast EPS vs Actual EPS